The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

Mon, 20th Dec 2021 21:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Close Brothers Group PLC - London-based merchant bank - To fully redeem all outstanding GBP23.4 million 2027 callable dated subordinated notes.

----------

Gresham House Strategic PLC - investor in smaller UK public companies - Tenders 1.6 million shares in offer, which covers full scale-back available. As a result, will buy 939,838 shares at GBP15.51 each for GBP14.6 million, which total 27% of current share capital.

----------

VPC Specialty Lending Investments PLC - invests in asset-backed loans to businesses originated by non-bank lenders - Notes L&F Acquisition Corp enters definitive agreement to combine with ZeroFox. Through VPC Sponsor, company currently owns 130,220 Class B shares and 167,284 private placement warrants in L&F Acquisition, held at an aggregate cost basis of USD168,051. The transaction implies an approximately USD1.4 billion post-merger pro forma equity value at a USD10.00 price per share of common stock. Following the deal, VSL's Class B shares will automatically convert into one share of ZeroFox common stock, with an implied transaction value of USD1.3 million.

----------

Plaza Centers NV - property investor in India - Extends long stop date for sale of its subsidiary which holds 75% in the Casa Radio project to AFI Europe NV to December 31, 2022.

----------

Grit Real Estate Income Group Ltd - pan-African property investment and management - Raises total of USD76.1 million from issue of 49.2 million shares in open offer and placing. Shares were priced at USD0.52. Non-Executive Chair Peter Todd says: "We are pleased by the success of the issue, and, on behalf of the board, I would like to thank existing and new shareholders for their support. The success of the issue reflects our confidence in both reducing Grit's overall levels of debt and driving further expansion in our core and expanded business, which we expect will deliver enhanced value to our shareholders. The Grit board expects to resume dividend payments in the current financial year, distributing out of net operating income generated from our existing property assets."

----------

Silver Bullet Data Services Group PLC - London-based provider of digital transformation services and products - Victim of cyber attack by "sophisticated hackers". Says hackers solicited falsified payments of GBP365,000 from its corporate bank account. Notes theft reported to the police, company's insurers and the Information Commissioner's Office. "This attack in no way affects the group's ability to perform day-to-day operations. The company continues to have a strong cash position and is exploring all avenues for the restitution of the funds and will update the market on this in due course," company explains.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based products using printed circuit technology - Confirms receipt of the second quarter 2022 purchase order of GBP2.4 million, as part of its product manufacture & supply agreement, with its UK EV OEM customer. Follows GBP390,000 purchase order for Q1 2022. "The agreement is for the supply of the company's Improved Harness Technology-enabled flexible printed circuit boards for use in high and low voltage circuits in the manufacturer's vehicle battery modules and battery packs. Trackwise's technology reduces part count and assembly time while saving on space and weight," company explains.

----------

Severfield PLC - Thirsk, North Yorkshire-based structural steel maker - Completes refinancing of its revolving credit facility with its current banking syndicate. New facility adds GBP50 million above GBP25 million currently and extends term of facility to December 2026. "The new facility provides the group with enhanced liquidity and long-term financing to help support its growth strategy," company explains.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based bio-pharmaceutical company - Begins clinical study with partners Swiss PharmaCan AG and Glow LifeTech Ltd to determine the influence of MGC Pharma's proprietary supplement ArtemiC Support in patients with Long Covid syndrome. The study will enrol 150 patients suffering from post-acute Covid syndrome with 50 patients already enrolled, and is expected to be completed in February 2022. "This is a pilot study to initially obtain partial results on the effectiveness and safety of ArtemiC Support in improving the functional status and symptomatology in patients suffering from Long Covid Syndrome," company says. Adds: "A further randomised, double-blind, placebo-controlled study, to get full information on efficacy and safety of the food supplement in patients suffering from Long-Covid is expected to follow, dependent on the results of the initial pilot study."

----------

Chill Brands Group PLC - Grand Junction, Colorado-based cannabidiol products - Partners with the US Major Arena Soccer League, to offer company's CBD products to the league and member teams. "The partners will also create the Chill Athlete's Lab which is designed to explore and implement the use of CBD to help athletes reach their top potential," company explains. The Major Arena Soccer League represents 16 teams across the US and Mexico.

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical products for sexual health and pain - Completes US Food & Drug Administration required additional 6-month confirmatory clinical study, known as FM71, for gel formulation for treatment of erectile dysfunction MED3000 taking a "least burdensome approach". "Overall, there was a very high degree of comprehension of the label and leaflet to increase confidence that the product will be used appropriately in an OTC setting. These results therefore support the regulatory submission for OTC designation and enable Futura to finalise the OTC product label for a US filing," company says. Timelines remain on track to enable planned US regulatory submission by the end of Q3 2022, and for targeting US OTC FDA approval of MED3000 in Q1 2023.

----------

Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Alongside University of Navarra in Spain, initiates clinical trial deploying nasal photodisinfection for a new variant-agnostic approach to stop SARS-CoV-2 replication in high-risk viral carriers. Study will look into impact of nasal decolonization on asymptomatic SARS-CoV-2 infected individuals. Chief Executive Carolyn Cross says: "The continuing emergence of SARS-CoV-2 variants such as Omicron, demonstrates that this research is more important than ever. Ondine Biomedical's laboratory work, as well as that of researchers at the University of Navarra, have demonstrated that our photodisinfection technology is extremely effective against SARS-CoV-2."

----------

Hemogenyx Pharmaceuticals PLC - London-based developer of drugs for blood diseases - Partners with WuXi Advanced Therapies to manufacture lentiviral vectors for phase I trial of HEMO-CAR-T programme, which will look into acute myeloid leukaemia. "HEMO-CAR-T cells are made using the Company's proprietary humanised monoclonal antibody against a target on the surface of AML cells. This cutting-edge application of cell-based immune therapy offers a potentially more benign and effective form of therapy that, if successful, could have a major impact on treatment and survival rates for AML. HEMO-CAR-T is planned to be the company's first therapeutic candidate to enter clinical trials," company says.

----------

Abingdon Health PLC - York-based lateral flow test maker - Raises GBP1 million from oversubscribed open offer following shareholder approval. Gets 7.3 million valid acceptances in open offer. As a result, raises total of GBP6.5 million from placing, subscription and PrimaryBid offer. Abingdon says the cash will be used for working capital ahead of anticipated order inflow for its Covid-19 tests.

----------

Savannah Energy PLC - African‑focused energy company - Hopes to have shares readmitted to AIM on or around December 22. Reaches agreement in principle with the Niger Ministry of Petroleum to formally renounce the R1/R2 PSC and the R3/R4 PSC and to combine the R1/R2 PSC Area with the R3/R4 PSC Area into one amalgamated R1234 PSC. Expects R1234 PSC will become effective in first quarter of 2022 and will reset licence validity to up to 10 years for the exploration phase, comprising an initial term of four years, with the option to extend this term by two further terms of two years each.

----------

Power Metal Resources PLC - London-based exploration and development company - Completes Phase I exploration at three of its seven uranium properties in Canada, namely Tait Hill, Thibault Lake and Cleawater. Notes projects in Athabasca Basin in northern Saskatchewan, Canada. Says 20 rock samples were collected for assay testing and the results demonstrate high grade uranium with the highest grade of 38,600 parts per million or 3.86% uranium oxide. Chief Executive Paul Johnson says: "The confirmation of high grade uranium through assay testing of rock samples samples from the recent exploration programme is extremely positive and demonstrates the value of the diligent review work undertaken when the footprint was selected for staking earlier in the year."

----------

Empire Metals Ltd - Gold and copper miner with assets in Australia, Georgia and Austria - Will start new series of drilling programmes in first quarter of 2022 at Eclipse gold project in Eastern Goldfields of Western Australia. Shaun Bunn, managing director, says: "A thorough and rigorous assessment of the data collected to date has been completed, leading to a much better understanding of the geological and structural controls of the gold mineralisation, which is vital for designing and implementing the next phase of exploration. The analysis by our technical team has confirmed that gold mineralisation at Eclipse is associated with a NW-striking and steeply SW-dipping shear zone with significant gold mineralisation known to extend over a strike length of more than 200 metres."

----------

Oriole Resources PLC - exploration company operating in west Africa - Recently completes Phase 2 diamond drilling programme at its 90%-owned Bibemi gold project in Cameroon. The programme focussed on the Bakassi Zone 1 prospect and has delivered best mineralised intervals of 6.50 metres grading 3.92 grammes per tonne gold including 1.00 metres grading 16.79 grammes per tonne gold, 5.20 metres grading 1.97 grammes per tonne gold and 2.25 metres grading 8.82 grammes per tonne gold including 1.00 metres grading 19.33 grammes per tonne gold. A follow-up programme of infill and extension drilling is nearing completion and results are anticipated in the first quarter of 2022.

----------

African Pioneer PLC - Isle of Man-based natural resources company - Increases measured indicated resources at 85%-owned Ongombo copper mine project in Namibia. Resources upped to 10.5 million tonnes at 1.4% copper, 7 grammes per tonne gold. Executive Chair Colin Bird says: "The company intends to progress all pertinent matters in order to bring the proposed mine into operation as soon as possible and will provide further updates as appropriate. As an order of magnitude, we are targeting a mine to process some 400,000 to 500,000 tonnes per annum with a copper production in the region of some 7,000 to 8,000 tonnes per annum. This mining plan is coincident with our stated ambition to join the small copper mining sector which internationally has largely been eliminated and, in our opinion, will be an important component of tomorrow's copper production. The deposit limits are not yet fully defined and we will be carrying out further investigations to either increase mine production or extend mine life."

----------

Zoltav Resources Inc - Russia-focused oil and gas explorer and producer - Plans to delist shares from London's AIM following share purchase agreement with ARA Capital. Notes ARA Capital to buy 62.6 million Zoltav shares from Bandbear for RUB1.8 billion or around USD24.3 million. "Zoltav has no significant UK based institutional investors among its Shareholders and its focus on oil and gas assets solely in Russia, together with the composition of its share register, mean that it is unlikely the business will be able to raise finance through the issue of new shares on AIM, which is one of the primary reasons for being listed," company says. Also says listing does not generally provide an opportunity to trade in meaningful volumes and will look to clear USD500,000 of costs with delisting. Plans expansion of its activities through a phased commissioning of five new fields: Pavlovskoye in February 2022; Lipovskoye in July 2022; Nepryakhinskoye in March 2023; Mokrousovskoye in 2028; and West Lipovskoye in 2030.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2023 08:25

IN BRIEF: MGC Pharmaceuticals raises GBP650,000 in subscription

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Conditionally raises GBP650,000, before expenses, through a placing and subscription of 541.7 million shares at a price of 0.12 pence per share. This represents a 57% discount from the closing price of 0.28p per share on Wednesday. The company also raises GBP50,000 from its Chief Executive Officer & Managing Director Roby Zomer in a convertible loan agreement.

Read more
12 Jul 2023 11:12

IN BRIEF: MGC Pharma to receive USD150,000 downpayment for AMC order

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Clarifies that it will receive USD150,000 down payment on a USD1 million order for ArtemiC placed by AMC last week. Says further USD850,000 will be paid upon completion of production and dispatch of the order, expected for September.

Read more
7 Jul 2023 09:41

MGC Pharmaceuticals shares up after USD1 million ArtemiC order

(Alliance News) - MGC Pharmaceuticals Ltd shares jumped on Friday morning after it announced a USD1 million order from AMC Pharma to produce ArtemiC, an over-the-counter version of CimetrA.

Read more
3 Jul 2023 17:31

TRADING UPDATES: Mycelx wins deal; 88 Energy buys in Texas

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 May 2023 12:09

IN BRIEF: MGC Pharmaceuticals epilepsy treatment delivered in UK

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product, CannEpil, has been successfully delivered to its first UK patients through I Am Billy Foundation. Says CannEpil also has been delivered to its first patient in the UK through a named patient request programme.

Read more
30 May 2023 18:27

IN BRIEF: MGC Pharmaceuticals rejigs board to reflect strategic change

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital.

Read more
13 Apr 2023 17:50

IN BRIEF: MGC Pharmaceuticals completes GBP2.1 million fundraise

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Raises GBP2.1 million via a fundraising announced on Tuesday, which has now closed. Shares issued under the placing will be admitted to London Stock Exchange on April 18. In addition, MGC secures GBP256,590 in a separate offer to Australian and UK high-net-worth investors.

Read more
11 Apr 2023 14:10

IN BRIEF: MGC Pharmaceuticals says CannEpil available in UK

MGC Pharmaceuticals Ltd - Perth, Australia-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product CannEpil for patients suffering from refractory epilepsy is now available in the UK by named patient request to be prescribed by doctors. The product is now in the process of a clinical development programme.

Read more
3 Apr 2023 14:32

TRADING UPDATES: Lords Group buys Chiltern Timber; SRT wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News:

Read more
21 Mar 2023 13:58

MGC Pharma's Covid-19 drug ArtemiC available over-the-counter in US

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said its ArtemiC product has now been listed as an over-the-counter, non-prescription drug in the US, while its supply and distribution partner AMC Holdings Inc has placed a USD2 million order.

Read more
15 Mar 2023 15:36

TRADING UPDATES: SigmaRoc Sweden boost; Mosman's Cinnabar-1 success

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
8 Mar 2023 18:24

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News:

Read more
28 Feb 2023 14:34

EARNINGS UPDATES: Kitwave hails rise in annual revenue and profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.